相似文献
1
Current Treatment of Alopecia Areata.
J Investig Dermatol Symp Proc. 2020 Nov;20(1):S28-S30. doi: 10.1016/j.jisp.2020.04.004.
2
Alopecia Areata: The Clinical Situation.
J Investig Dermatol Symp Proc. 2018 Jan;19(1):S9-S11. doi: 10.1016/j.jisp.2017.10.015.
3
Alopecia Areata-Part III: Prognosis and Treatment.
Skinmed. 2016 Oct 1;14(5):361-365. eCollection 2016.
4
Current treatment of alopecia areata.
J Investig Dermatol Symp Proc. 2013 Dec;16(1):S42-4. doi: 10.1038/jidsymp.2013.14.
5
Treatment Options for Alopecia Areata in Children and Adolescents.
Paediatr Drugs. 2024 May;26(3):245-257. doi: 10.1007/s40272-024-00620-2. Epub 2024 Mar 11.
6
Alopecia areata.
Curr Probl Dermatol. 2015;47:67-75. doi: 10.1159/000369406. Epub 2015 Feb 20.
7
Treatment of Alopecia Areata in the United States: A Retrospective Cross-Sectional Study.
J Drugs Dermatol. 2015 Sep;14(9):1012-4.
8
JAK Inhibitors for Treatment of Alopecia Areata.
J Invest Dermatol. 2018 Sep;138(9):1911-1916. doi: 10.1016/j.jid.2018.05.027. Epub 2018 Jul 26.
9
Janus kinase inhibitors for alopecia areata.
J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049.
10
Alopecia areata: what to expect from current treatments.
Cleve Clin J Med. 2005 Sep;72(9):758, 760-1, 765-6 passim. doi: 10.3949/ccjm.72.9.758.
引用本文的文献
1
From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology.
Front Immunol. 2025 Sep 1;16:1621492. doi: 10.3389/fimmu.2025.1621492. eCollection 2025.
2
A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.
J Dermatol. 2024 Sep;51(9):1157-1171. doi: 10.1111/1346-8138.17381. Epub 2024 Jul 25.
本文引用的文献
1
Response to: "Rethinking biotin therapy for hair, nail, and skin disorders".
J Am Acad Dermatol. 2018 Dec;79(6):e121-e124. doi: 10.1016/j.jaad.2018.07.055. Epub 2018 Aug 7.
2
Rethinking biotin therapy for hair, nail, and skin disorders.
J Am Acad Dermatol. 2018 Jun;78(6):1236-1238. doi: 10.1016/j.jaad.2018.02.018. Epub 2018 Feb 10.
3
Objective outcome measures: Collecting meaningful data on alopecia areata.
J Am Acad Dermatol. 2018 Sep;79(3):470-478.e3. doi: 10.1016/j.jaad.2017.10.048. Epub 2017 Nov 8.
4
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2.
5
Tofacitinib for the treatment of alopecia areata and variants in adolescents.
J Am Acad Dermatol. 2017 Jan;76(1):29-32. doi: 10.1016/j.jaad.2016.09.006. Epub 2016 Nov 2.
6
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.
JCI Insight. 2016 Sep 22;1(15):e89790. doi: 10.1172/jci.insight.89790.
7
Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.
Exp Dermatol. 2016 Aug;25(8):642-3. doi: 10.1111/exd.13060.
8
Topical Ruxolitinib for the Treatment of Alopecia Universalis.
JAMA Dermatol. 2016 Apr;152(4):490-1. doi: 10.1001/jamadermatol.2015.4445.
9
Treatment of alopecia areata with simvastatin/ezetimibe.
J Am Acad Dermatol. 2015 Feb;72(2):359-61. doi: 10.1016/j.jaad.2014.11.006.
10
Alopecia areata: an evidence-based treatment update.
Am J Clin Dermatol. 2014 Jul;15(3):231-46. doi: 10.1007/s40257-014-0086-4.
Zotero 插件